Showing results (2051-2060 of 2,466) with videos related to

Sort By:
Pageof 247
Mucosal Immunology|April 30, 2015
Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriageS Glennie, J F Gritzfeld, S H Pennington, et al.
Scientific Reports|August 30, 2025
Engineered spermidine-secreting Saccharomyces boulardii ameliorates colitis and colon cancer in miceMahdi Mohaqiq, Roger Palou, Ruizhen Li, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
RGS10 Attenuates Systemic Immune Dysregulation Induced by Chronic Inflammatory StressJanna E Jernigan, Hannah A Staley, Zachary Baty, et al.
Journal of Neuroinflammation|February 25, 2025
RGS10 attenuates systemic immune dysregulation induced by chronic inflammatory stressJanna E Jernigan, Hannah A Staley, Zachary Baty, et al.
The Lancet. Psychiatry|May 15, 2022
Improving lithium dose prediction using population pharmacokinetics and pharmacogenomics: a cohort genome-wide association study in SwedenVincent Millischer, Granville J Matheson, Sarah E Bergen, et al.
BMC Health Services Research|June 9, 2023
Discharge interventions for First Nations people with a chronic condition or injury: a systematic reviewJulieann Coombes, Andrew J A Holland, Courtney Ryder, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 26, 2023
A genome-wide association study of antidepressant-induced maniaClement C Zai, Alessio Squassina, Arun K Tiwari, et al.
The Journal of Biological Chemistry|May 14, 2011
Quantitative mass spectrometry catalogues Salmonella pathogenicity island-2 effectors and identifies their cognate host binding partnersSigrid D Auweter, Amit P Bhavsar, Carmen L de Hoog, et al.
Breast Cancer Research and Treatment|April 6, 2012
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept studyMarta Pestrin, Silvia Bessi, Fabio Puglisi, et al.
The Lancet. Oncology|June 1, 2005
Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trialAndreas Polychronis, H Dudley Sinnett, Dimitri Hadjiminas, et al.
Pageof 247